Ring finger protein 222," encoded by the gene "21618," is a member of the RING (Really Interesting New Gene) family of proteins, which are characterized by the presence of a RING finger domain. This domain typically consists of a C3HC4 amino acid motif that binds two zinc ions, and it is integral to the protein's role in mediating a variety of cellular processes.The gene "21618" serves as a unique identifier within a genomic database, pinpointing the specific genetic sequence that codes for the ring finger protein 222. This protein, through its RING finger domain, is often involved in ubiquitination, a post-translational modification process where ubiquitin molecules are attached to substrate proteins. Ubiquitination can signal for protein degradation via the proteasome, alter protein function, or affect protein localization within the cell.
As with other RING finger proteins, ring finger protein 222 may act as an E3 ubiquitin ligase, which plays a crucial role in the transfer of ubiquitin from the E2 conjugating enzyme to specific substrate proteins. The specificity of the ubiquitination process is largely determined by the E3 ligase, thus ring finger protein 222 may be involved in targeting specific proteins for ubiquitination, influencing various cellular pathways including cell cycle regulation, DNA repair, signal transduction, and transcriptional regulation.The detailed functions of ring finger protein 222 are likely to be context-dependent, varying with cell type, developmental stage, and external stimuli. Studying this protein's interactions and ubiquitination targets could provide valuable insights into the intricate regulatory networks within cells. Disruptions in the function of RING finger proteins like ring finger protein 222 are associated with a range of diseases, including cancer, neurodegenerative disorders, and immune system dysfunctions, due to their pivotal roles in controlling protein homeostasis and signaling pathways.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG-132 is a proteasome inhibitor that could indirectly affect the ubiquitin-mediated processes involving RNF222. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib is another proteasome inhibitor, potentially impacting protein degradation pathways involving RNF222. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Lactacystin inhibits the proteasome, potentially affecting the function of ubiquitin ligases like RNF222. | ||||||
ATM/ATR Kinase Inhibitor Inhibitor | 905973-89-9 | sc-202964 | 5 mg | $104.00 | 8 | |
MLN4924 inhibits NEDD8-activating enzyme, affecting ubiquitin-like protein conjugation pathways and possibly RNF222. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
PYR-41 is a ubiquitin-activating enzyme E1 inhibitor, potentially affecting RNF222's ubiquitin-related activity. | ||||||
PR 619 | 2645-32-1 | sc-476324 sc-476324A sc-476324B | 1 mg 5 mg 25 mg | $75.00 $184.00 $423.00 | 1 | |
PR-619 is a broad-spectrum deubiquitinase inhibitor, potentially impacting RNF222's related pathways. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Thalidomide has been shown to target the ubiquitin-proteasome system, potentially affecting RNF222. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $40.00 | ||
Carfilzomib is a selective proteasome inhibitor, potentially influencing RNF222-related processes. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
Epoxomicin is a proteasome inhibitor, potentially affecting ubiquitin-related functions of RNF222. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $165.00 | ||
TAK-243 is a ubiquitin-activating enzyme E1 inhibitor, potentially influencing RNF222. | ||||||